Real-life efficacy and safety of daclatasvir and asunaprevir therapy for genotype 1b chronic hepatitis C patients without NS5A resistance-associated substitution: A nationwide study in South Korea
2018 ◽
Vol 68
◽
pp. S299-S300
◽
Keyword(s):
2018 ◽
Vol 12
(2)
◽
pp. 133-142
◽
2016 ◽
Vol 64
(2)
◽
pp. S765-S766
◽
Keyword(s):
2017 ◽
Vol 32
(6)
◽
pp. 1230-1233
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):